aHUS-associated autoantibodies to CFH19–20 cause uncontrolled complement attack against host cells, and autoantibodies from some patients have been shown to impair CFH binding to C3b or to host cells (11). The gene discussed is CFH; the disease is atypical hemolytic-uremic syndrome.